Twist Bioscience Corp

NASDAQ:TWST   3:59:57 PM EDT
48.50
-8.06 (-14.25%)
Positive Earnings Pre-Announcement

Twist Bioscience Reports Q3 2022 Financial Results

Published: 08/05/2022 11:39 GMT
Twist Bioscience Corp (TWST) - Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results.
Q3 Loss per Share $1.08.
Sees FY Revenue $203 Million.
Q3 Revenue Rose 60 Percent to $56.1 Million.
Says Increases Revenue Guidance to $203 Million for Full Year Fiscal 2022.
Q3 Earnings per Share View $-1.31, Revenue View $51.5 Million -- Refinitiv Ibes Data (analyst estimates).
Increases Revenue Guidance to $203 Million for Full Year Fiscal 2022.
FY2022 Revenue View $196.9 Million -- Refinitiv Ibes Data (analyst estimates).
Says Capital Expenditures Expected to Be in Range of $95 to $100 Million for Full Year.
Revenue is expected to be $56.92 Million
Adjusted EPS is expected to be -$1.30

Next Quarter Revenue Guidance is expected to be $57.63 Million
Next Quarter EPS Guidance is expected to be -$1.16

More details on our Analysts Page.